Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on the following share repurchase data for June 2, 2025:
- Shares Purchased: 794,623 ordinary shares
- Highest Price Paid: 417.60 pence per share
- Lowest Price Paid: 412.30 pence per share
- Volume Weighted Average Price: 414.05 pence per share
- Purpose: Cancellation of shares
Following this transaction, the company's registered share capital stands at 9,004,535,562 ordinary shares. Of these, 4,080,205 are held as treasury shares, resulting in 9,000,455,357 ordinary shares with voting rights.
Material Changes
The filing reports a reduction in the number of outstanding shares with voting rights due to the cancellation of 794,623 shares. No other material changes to financial position or operations are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a routine disclosure of a completed share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction timing.
- Check subsequent filings for updated treasury share counts and voting rights calculations.